No profile data available.
Staar Surgical Company (STAA) is a healthcare company in the targeted healthcare equipment industry, based in Lake Forest, United States, with about 1,157 full-time employees.
It reported revenue of $239.44 million for fiscal year 2026, down 23.7% from fiscal year 2024, and net income of -$80.45 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $93.54 million, up 111.0% from a year before. Other was its largest region in fiscal year 2025, with 39% of revenue. Its market capitalization was $1.31 billion as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
Staar Surgical reported $239.44 million in revenue for fiscal year 2026, down 23.7% from $313.90 million in fiscal year 2024. In Q2 2026 revenue was $93.54 million.
Other: 39% of revenue by region in fiscal year 2025, followed by China (32%).
$1.31 billion as of December 4, 2025.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include NovoCure Limited (NVCR), Nolato AB (publ) (NLTBF), Alpha Tau Medical Ltd. (DRTS), Nanobiotix S.a. (NBTX).